| Page 15 | Kisaco Research
  • Concrete guidance on accessing non-dilutive and dilutive funding - what’s available, what’s working, and how to get it.
  • Strategies for founders and funders to navigate uncertainty and build investable, scalable ventures in women's health.
  • How women, as both innovators and investors, are transforming the funding ecosystem - and how to leverage that shift now.
Digital Health
Innovation and Investment

Author:

Lisa Marceau

CEO
Joyuus
... read more

Lisa Marceau

CEO
Joyuus
  • Sharing new clinical outcomes and how clinical trials are evolving.
  • Exploring the link between menopause, estrogen, and cognitive decline.
  • How biomarkers, digital tools, and lifestyle interventions can improve outcomes.
Brain Health
  • Sharing the role of technology and partnerships in the design & recruitment of studies.
  • Highlighting adaptive trial designs, decentralized models, and inclusive recruitment strategies.
  • Exploring how smarter trial design accelerates approval, reduces risk, and improves real-world outcomes.
Reproductive Health
Drug Development
Med Device
  • Demystifying product-market fit in the context of digital health, where clinical need, usability, and reimbursement must align.
  • Identifying key indicators—user adoption, engagement, and outcomes—that show readiness to scale.
  • Strategies for translating validated need into scalable, sustainable digital health solutions.
Innovation and Investment
  • Discuss strategies for trial design that account for hormonal fluctuations, comorbidities, and age-related variables unique to the menopausal transition.
  • Highlight regulatory, industry, and advocacy efforts that are pushing for menopause-specific representation in therapeutic areas beyond just women’s health.
  • Sharing advancements to educate clinical trial patients about menopause.
Menopause and Longevity
Drug Development
 

Johan van Hylckama

CSO
Freya Biosciences

Johan van Hylckama

CSO
Freya Biosciences

Johan van Hylckama

CSO
Freya Biosciences
  • Expanding access to mammograms and diagnostics in underserved communities.
  • Personalizing Risk Assessment & Early Detection, how AI, genetic testing, and targeted outreach are improving outcomes.
  • The adoption of innovation in breast & cervical cancer screening centred around patient centricity.
Oncology
Digital Health
  • How the demand for menopause-focused functional foods, probiotics, and supplements is shaping new business opportunities.
  • Sharing insights into how nutrition and food as medicine links bone, heart, and brain health in menopause and the opportunity to address these health outcomes through wellness.
  • Expanding access to menopause nutrition solutions through pharmacies, e-commerce, consumer wellness, and employer plans.
Menopause and Longevity
Nutrition and Food as Medicine

Author:

Jacqueline Oliveira-Cella

Founder
wellBe Consulting
... read more

Jacqueline Oliveira-Cella

Founder
wellBe Consulting

Author:

Laura Katz

CEO
Helaina
... read more

Laura Katz

CEO
Helaina